Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants

por Ng, Kuan H., Hart, Robert G., Eikelboom, John W.
Publicado 2013

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation

por Diener, Hans-Christoph, Hankey, Graeme J, Easton, J Donald, Lip, Gregory Y H, Hart, Robert G, Caso, Valeria
Publicado 2020

Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis

por Hariharan, Nikhil Nair, Patel, Kashyap, Sikder, Omaike, Perera, Kanjana S, Diener, Hans-Christoph, Hart, Robert G, Eikelboom, John W
Publicado 2022

Who says “no” to participating in stroke clinical trials and why: an observational study from the Vancouver Stroke Program

por O’Neill, Zoe R., Deptuck, Halina M., Quong, Lauren, Maclean, Genoveva, Villaluna, Karina, King-Azote, Princess, Sharma, Mukul, Butcher, Ken, Hart, Robert G., Field, Thalia S.
Publicado 2019

Are large simple trials for dementia prevention possible?

por Whiteley, William N, Anand, Sonia, Bangdiwala, Shrikant I, Bosch, Jackie, Canavan, Michelle, Chertkow, Howard, Gerstein, Hertzel C, Gorelick, Philip, O’Donnell, Martin, Paré, Guillaume, Pigeyre, Marie, Seshadri, Sudha, Sharma, Mike, Smith, Eric E, Williamson, Jeff, Cukierman-Yaffe, Tali, Hart, Robert G, Yusuf, Salim
Publicado 2020

Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy

por Sharma, Mukul, Smith, Eric E, Pearce, Lesly A, Perera, Kanjana S, Kasner, Scott E, Yoon, Byung-Woo, Ameriso, Sebastian F, Puig, Josep, Damgaard, Dorte, Fiebach, Jochen B, Muir, Keith W, Veltkamp, Roland C, Toni, Danilo S, Shamalov, Nikolay, Gagliardi, Rubens J, Mikulik, Robert, Engelter, Stefan T, Bereczki, Daniel, O’Donnell, Martin J, Saad, Feryal, Shoamanesh, Ashkan, Berkowitz, Scott D, Mundl, Hardi, Hart, Robert G
Publicado 2021